Results 21 to 30 of about 491,654 (151)

Immunometabolic mechanisms of osteosarcopenic obesity: chronic inflammation, trained immunity, and systemic immune dysregulation [PDF]

Frontiers in Immunology
Osteosarcopenic obesity (OSO)—the co-occurrence of osteoporosis/osteopenia, sarcopenia, and excess adiposity—is increasingly recognized in ageing populations and is strongly linked to frailty, fractures, disability, and cardiometabolic complications ...
Haobo Jiang, Haobo Jiang, Yuting Zhang, Zicheng Luo, Xiaofei Tang, Yiyou He, Guangliang Hao   +6 more
doaj   +2 more sources

A Scoping Review on the Serum Biomarkers of Osteosarcopenic Obesity [PDF]

Proceedings
Background and objectives: Osteosarcopenic obesity/adiposity (OSO/OSA) syndrome describes the concurrent deterioration of bone, muscle, and adipose tissue. The objective of this review was to evaluate human studies addressing serum biomarkers in relation
Vesna Vucic, Danijela Ristic-Medic, Aleksandra Arsic, Snjezana Petrovic, Marija Paunovic, Jasminka Z. Ilich   +5 more
doaj   +2 more sources

Association between osteosarcopenic obesity and hypertension among four minority populations in China: a cross-sectional study [PDF]

BMJ Open, 2019
Objective Osteosarcopenic obesity (OSO) may be associated with an increased prevalence of hypertension. The aim of this study was to examine the difference in the prevalence of OSO and hypertension among four minority populations in China and explore the
Peng Liu, Xingcai Chen, Cunqing Kong, Hongrong Yu, Jiangu Gong, Ling Lan, Lining Zhou, Jichun Gong, Lin Xu, Qiongying Deng   +9 more
doaj   +2 more sources

Vitamin D in the elderly: the phil-rouge in preventing bone, muscle and adipose deterioration? [PDF]

Archives of Endocrinology and Metabolism
The pleiotropic role of vitamin D in human health has been implicated in modulating bone metabolism and other several extraskeletal areas, including muscle and adipose tissues regulation, and in influencing general and systemic outcomes.
Luigi di Filippo, Umberto Terenzi, Andrea Giustina   +2 more
doaj   +2 more sources

Research trends in nutrition and exercise for sarcopenic obesity: a bibliometric analysis [PDF]

Frontiers in Nutrition
ObjectivesWith global population aging and obesity rates rising, the prevalence of sarcopenic obesity (SO) is being rapidly increased, resulting in significant health impacts and making it a growing public health concern in academic circles. Exercise and
Guoqing Zhang, Juncui Hu, Juncui Hu, Chanjuan Chen, Wenyan Zhu, Yingyi Chen, Yi Cheng, Wen Hu, Zhiyong Rao   +8 more
doaj   +2 more sources

The Role of Nutrition in Osteosarcopenic Obesity: Lessons Learned during the Last 10 Years and Future Horizons. [PDF]

Nutrients, 2023
: The term Osteosarcopenic Obesity (OSO) was introduced for the first time in 2014 by Ilic et al [...]
Perna S, Rondanelli M.
europepmc   +2 more sources

Clinical Manifestations and Factors Associated with Osteosarcopenic Obesity Syndrome: A Cross-Sectional Study in Koreans with Obesity

Calcified Tissue International, 2019
Demonstrating the clinical consequences of osteosarcopenic obesity (OSO) is complex. This study evaluated clinical manifestations and factors associated with bone and muscle loss in Koreans with obesity. This cross-sectional observational study enrolled Koreans with obesity aged ≥ 50 years from the Korea National Health and Nutrition Examination Survey.
Yoo Mee, Kim, Sunghoon, Kim, Young Jun, Won, Se Hwa, Kim   +3 more
openaire   +4 more sources

Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease

Diabetes, Metabolic Syndrome and Obesity, 2020
Valentina Guarnotta, Antonio Prinzi, Maria Pitrone, Giuseppe Pizzolanti, Carla Giordano Dipartimento di Promozione Della Salute, Materno-Infantile, Medicina Interna e Specialistica di Eccellenza “G.
Guarnotta V, Prinzi A, Pitrone M, Pizzolanti G, Giordano C   +4 more
doaj   +3 more sources

Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing's Disease. [PDF]

Diabetes Metab Syndr Obes, 2020
To evaluate circulating irisin levels in patients with active and controlled Cushing's disease (CD).Forty-four patients with CD evaluated during the active phase and after 12 months of biochemical remission and 40 controls were recruited.Phenotypic, anthropometric, hormonal and metabolic parameters, including insulin sensitivity estimation by ...
Guarnotta V, Prinzi A, Pitrone M, Pizzolanti G, Giordano C.   +4 more
europepmc   +4 more sources

Preventing Osteoporosis, Sarcopenia and Obesity to Care about Quality of Life [PDF]

Annals of Geriatric Medicine and Research, 2023
A recent review by Kumari and Khanna examined the prevalence of sarcopenic obesity using various comorbidities, diagnostic markers, and possible therapeutic approaches. The authors discussed the strong impact of sarcopenic obesity on quality of life (QoL)
Stefano Cacciatore, Claudia Massaro, Francesco Landi   +2 more
doaj   +1 more source